AbbVie Inc (ABBV)

Index:

S&P 100

$ 177.84
   
  • Change Today:
    $0.89
  • 52 Week High: $203.87
  • 52 Week Low: $138.08
  • Currency: US Dollars
  • Shares Issued: 1,765.94m
  • Volume: 4,225,467
  • Market Cap: $314,055m
  • RiskGrade: 122
  • Beta: 0.19

Latest ShareCast News

AstraZeneca sells hypertension drug rights; Ends Allergan deal

By Frank Prenesti

Date: Monday 27 Jan 2020

(Sharecast News) - AstraZeneca said it had agreed to sell the global commercial rights to a range of hypertension treatments to Atnahs Pharma for up to $390m.

Botox maker Allergan reports jump in third-quarter revenues

By Abigail Townsend

Date: Tuesday 05 Nov 2019

(Sharecast News) - Botox maker Allergan, which is being taken over in a $63bn blockbuster deal, has upped its full-year guidance after posting a forecast-beating set of third-quarter numbers.

Abbvie snaps up Botox-maker Allergan in $63bn deal

By Iain Gilbert

Date: Tuesday 25 Jun 2019

(Sharecast News) - Chicago-based biopharmaceutical company Abbvie snapped up Botox-maker Allergan for roughly $63bn on Tuesday, mostly in cash.

Pharma firms to testify in Congress over drug pr... 26-Feb-2019 ShareCast
 
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AbbVie Inc Market Data

Currency US Dollars
Share Price $ 177.84
Change Today $ 0.89
% Change 0.50 %
52 Week High $203.87
52 Week Low $138.08
Volume 4,225,467
Shares Issued 1,765.94m
Market Cap $314,055m
Beta 0.19
RiskGrade 122

What The Brokers Say

Strong Buy 6
Buy 15
Neutral 7
Sell 0
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-Nov-2024

Time Volume / Share Price
13:53 100 @ $177.84
13:53 100 @ $177.84
13:53 100 @ $177.84
13:53 100 @ $177.82
13:53 100 @ $177.85

Top of Page